Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction

Abstract The aim of this study was to evaluate the effects of Sacubitril/Valsartan (S/V) on clinical, laboratory and echocardiographic parameters and outcomes in a real-world population with heart failure with reduced ejection fraction (HFrEF). This was a prospective observational study enrolling pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Vincenza Polito, Angelo Silverio, Antonella Rispoli, Gennaro Vitulano, Federica D’ Auria, Elena De Angelis, Francesco Loria, Alberto Gigantino, Domenico Bonadies, Rodolfo Citro, Albino Carrizzo, Gennaro Galasso, Guido Iaccarino, Carmine Vecchione, Michele Ciccarelli
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/c4eb79d743ba47cb96ae9674c35a7a14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c4eb79d743ba47cb96ae9674c35a7a14

Ejemplares similares